)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Neuphoria Therapeutics
Neuphoria Therapeutics (NEUP) investor relations material
Neuphoria Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary18 Sep, 2026
Executive summary
Annual meeting scheduled for November 2, 2026, to be held virtually at 9:00 a.m. Eastern Time.
Proxy materials are available online, with options for electronic or paper delivery upon request.
Shareholders are encouraged to review all proxy materials and vote online or by requesting a paper ballot.
Voting matters and shareholder proposals
Election of one Class II director, Alan Fisher, for a three-year term expiring at the 2029 annual meeting.
Ratification of Wolf & Company P.C. as independent registered public accounting firm for fiscal year ending June 30, 2027.
Approval of potential adjournments of the annual meeting to solicit additional proxies if needed.
Board of directors and corporate governance
Board recommends voting FOR the director nominee and FOR both other proposals on the agenda.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Neuphoria Therapeutics
- Annual Meeting to vote on director election, auditor ratification, and adjournment authorization.NEUP
Proxy filing - Annual meeting proxy materials are online for review and voting ahead of November 2, 2026.NEUPProxy filing
- FY26 saw a sharp revenue drop, major restructuring, and a $5.4M goodwill impairment amid a pending merger.NEUPQ4 2026
- All-share merger forms a Nasdaq-listed immunotherapy firm, backed by $89M in new financing.NEUPProxy filing
- BNC210 advances in late-stage trials for anxiety and PTSD, with strong Merck-backed Alzheimer's program.NEUPCorporate presentation
- Key clinical and financial milestones achieved, with cash runway through Q2 2027.NEUPQ4 2025
- Biotech seeks up to $100M for late-stage neuropsychiatric drug trials, leveraging ATM sales.NEUPRegistration filing
- Biopharma seeks up to $100M for CNS drug trials, with $2M ATM, amid US redomicile and Nasdaq risks.NEUPRegistration filing
- Net income surged on Merck milestone; BNC210 Phase 3 data expected Q3 2025, cash runway into 2027.NEUPQ3 2025
Next Neuphoria Therapeutics earnings date
Q1 202720 Nov, 2026
Neuphoria Therapeutics
Next Neuphoria Therapeutics earnings date
Q1 202720 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)